Wugen is a clinical-stage biotechnology company based in San Diego, CA and St. Louis, MO. They are focused on developing off-the-shelf cellular therapies for cancer, utilizing their innovative NK Platform and CAR-T Platform to engineer the next generation of cell therapies.
With a strong leadership team and scientific advisory board, Wugen is dedicated to advancing their pipeline of pre-clinical and clinical programs, including allogeneic T-ALL, LBL, AML, and solid tumors. Their commitment to optimizing cellular therapies through evolution sets them apart in the field of oncology.
Generated from the website